(Q48472690)

11 February 2018

title

Reduced central serotonergic activity in mania: implications for the relationship between depression and mania (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1125505

24 August 2022

Reduced Central Serotonergic Activity in Mania: Implications for the Relationship between Depression and Mania (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

5 October 2023

author name string

J. Mendels

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1125505

24 August 2022

A. Frazer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1125505

24 August 2022

language of work or name

English

0 references

publication date

1 March 1975

1 reference

11 February 2018

full work available at URL

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000070744

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

British Journal of Psychiatry

5 October 2023

published in

1 reference

11 February 2018

volume

126

1 reference

11 February 2018

page(s)

241-248

1 reference

11 February 2018

Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine

cites work

1

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Toward a biology of depression: some suggestions from neurophysiology

5 October 2023

2

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

The determination of 5-hydroxytryptamine in human urine

5 October 2023

5

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

5 October 2023

Methysergide in Mania

6

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

The Pharmacology of Imipramine and Related Antidepressants

5 October 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

A controlled study of the antidepressant effects of lithium carbonate

5 October 2023

8

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid

5 October 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

5 October 2023

12

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Depression During Mania: Clinical Observations and Theoretical Implications

5 October 2023

14

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

5 October 2023

L-Tryptophane and sleep

15

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

A clinical trial of methysergide and lithium in mania

5 October 2023

17

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Compulsive Sexual Activity Induced by p -Chlorophenylalanine in Normal and Pinealectomized Male Rats

5 October 2023

18

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus

5 October 2023

19

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Origin of 5-Hydroxyindoleacetic Acid in the Spinal Fluid

5 October 2023

24

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

5 October 2023

26

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

The biochemistry of affective disorders

5 October 2023

27

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Brain biogenic amine depletion and mood

5 October 2023

29

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Sequential comparison of L-tryptophan with E.C.T. in severe depression

5 October 2023

32

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Insomnia following parachlorophenylalanine in the rat.

5 October 2023

33

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Tryptophan concentration in the cerebrospinal fluid of depressive patients

5 October 2023

34

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Clinical-pharmacological evaluation of p-chlorophenylalanine: A new serotonin-depleting agent

5 October 2023

35

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Abnormalities of indoleamines in affective disorders.

5 October 2023

37

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

The effect of para-chlorophenylalanine on the sleep of cats.

5 October 2023

38

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan

5 October 2023

39

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

The central metabolism of serotonin in the cat during insomnia. A neurophysiological and biochemical study after administration of P-chlorophenylalanine or destruction of the Raphé system.

5 October 2023

40

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Tryptophan in the treatment of depression

5 October 2023

41

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?

5 October 2023

42

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

A double-blind intensive crossover design trial of methysergide in mania

5 October 2023

43

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

5 October 2023

44

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

5 October 2023

Lithium and depression

45

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid

5 October 2023

46

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Effects of chlorpromazine on the metabolism of catecholamines in dog brain

5 October 2023

47

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

5 October 2023

49

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Inhibition of Serotonin Synthesis by Para-Chlorophenylalanine in Patients with the Carcinoid Syndrome

5 October 2023

50

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

"Hypersexuality" and Behavioral Changes in Cats Caused by Administration of p -Chlorophenylalanine

5 October 2023

51

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Brain serotonin content: physiological dependence on plasma tryptophan levels.

5 October 2023

52

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Potentiation of a monoamine oxidase inhibitor by tryptophan

5 October 2023

54

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

5 October 2023

55

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Relationship between depression and mania

5 October 2023

56

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Tryptophan and sleep in young adults.

5 October 2023

57

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

5 October 2023

58

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Trial of Methysergide in Mania

5 October 2023

59

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Lithium Carbonate as a Mood and Total Body Water Stabilizer

5 October 2023

61

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Amine metabolism in the human brain: Further evaluation of the probenecid test

5 October 2023

64

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

5 October 2023

65

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Methysergide as a Treatment for Mania

5 October 2023

66

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

On the measurement of 5-hydroxyindoleacetic acid in cerebrospinal fluid

5 October 2023

68

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Sleep and depression. IV. Longitudinal studies

5 October 2023

71

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Biogenic Amine Metabolites in Cerebrospinal Fluid of Depressed and Manic Patients

5 October 2023

72

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

5 October 2023

73

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Body fluid distribution in manic and depressed patients treated with lithium carbonate

5 October 2023

75

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN

5 October 2023

76

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Lithium in psychiatric therapy and prophylaxis

5 October 2023

78

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

5 October 2023

79

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Therapeutic effect of pituitary adrenocorticotropic hormone (ACTH) in a case of Henoch-Schönlein vascular (anaphylactoid) purpura

5 October 2023

80

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Psychological response to corticotropin, cortisone, and related steroid substances; psychotic reaction types.

5 October 2023

81

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

The effect of parachlorophenylalanine on social interaction of male rats

5 October 2023

82

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

A therapeutic trial in migraine with parachlorophenylalanine, a specific serotonin depletor.

5 October 2023

84

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Effect of brain serotonin depletion on sleep in rats.

5 October 2023

85

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Biochemical and Pharmacological Variations in Manic-Depressive Illness

5 October 2023

86

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

5 October 2023

87

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

Sleep patterns of the monkey and brain serotonin concentration: effect of p-chlorophenylalanine.

5 October 2023

89

1 reference

https://api.crossref.org/works/10.1192/BJP.126.3.241

5 October 2023

Identifiers

1 reference

11 February 2018

1 reference

11 February 2018